Activity of soluble aminopeptidase A and dipeptidyl peptidase IV and membrane-bound aminopeptidase B and pyroglutamyl peptidase I in adenoid hyperplasia, tonsillar hyperplasia and chronic tonsillitis.
Gorka Larrinaga, Itxaro Perez, Begoña Sanz, Amaya Irazusta, Idoia Zarrazquin, Clara Elena Sanchez, Carmen Elena Sanchez, Ana Sanchez Del Rey, Aitor Zabala, Francisco Santaolalla
Index: Int. J. Pediatr. Otorhinolaryngol. 75 , 1399-1403, (2011)
Full Text: HTML
Abstract
To analyze soluble and membrane-bound peptidase activities in the tonsils and adenoids removed from patients with adenoid hyperplasia, tonsillar hyperplasia and chronic tonsillitis.A total of 48 tissue samples from patients undergoing adenoidectomy and tonsillectomy for adenoid hyperplasia, tonsillar hyperplasia or chronic tonsillitis were analyzed. The catalytic activity of a pool of peptidases in the soluble (dipeptidyl peptidase IV, aminopeptidase A, aminopeptidase N and cystinyl aminopeptidase) and membrane-bound (prolyl endopeptidase, aspartyl aminopeptidase, aminopeptidase B and pyroglutamyl peptidase I) fractions was measured fluorometrically.The activity of membrane-bound aminopeptidase B was higher in cases of chronic tonsillitis and adenoid hyperplasia than in tonsillar hyperplasia, p=0.004. Soluble dipeptidyl peptidase IV and membrane-bound pyroglutamyl peptidase I were found to be more active in tissues from male chronic tonsillitis tissues, p<0.05, while membrane-bound aminopeptidase B activity was higher in tissues of females with tonsillar hyperplasia, p<0.001. In the case of chronic tonsillitis, soluble aminopeptidase A was found to have a higher level of activity in tissues from children than those from adults, p=0.005.Our results suggest a potential role of soluble aminopeptidase A, soluble dipeptidyl peptidase IV, membrane-bound aminopeptidase B and membrane-bound pyroglutamyl peptidase I in the pathobiology of adenoid hyperplasia, tonsillar hyperplasia and chronic tonsillitis that is differently regulated as a function of gender. These finfings may modify in the future the clinical approach to these diseases.Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Related Compounds
Related Articles:
2008-07-04
[Neurosci. Lett. 439(1) , 75-8, (2008)]
2006-09-20
[J. Agric. Food Chem. 54(19) , 6984-8, (2006)]
2006-12-01
[Mol. Biochem. Parasitol. 150(2) , 318-29, (2006)]
2007-01-01
[Neurochem. Int. 50(2) , 404-17, (2007)]
2012-08-07
[Biochemistry 51(31) , 6089-96, (2012)]